HIGHLIGHTS
- who: Lan-Fang Li et al. from the Huazhong University of Science and Technology, China have published the research work: Therapeutic outcomes of mycophenolate mofetil and glucocorticoid in thyroid-associated ophthalmopathy patients, in the Journal: (JOURNAL)
- what: In this study, to provide novel insights into clinical TAO treatment the authors aimed to investigate the therapeutic effects and safety of MMF administration combined with glucocorticoids in TAO patients.
SUMMARY
Study subjects and methods Thyroid-associated ophthalmopathy (TAO) is an organ-specific autoimmune, which is the most common orbital disorder in adults. In . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.